XML 42 R35.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Preferred and Common Shares and Share-Based Compensation (Tables)
6 Months Ended
Jun. 28, 2024
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Share-Based Compensation Expense Recorded in the Consolidated Statements of Operations

The table below summarizes share-based compensation expense recorded in the consolidated statements of operations (in thousands):

 

Three Months Ended

 

 

Six Months Ended

 

 

June 28,

 

 

June 30,

 

 

June 28,

 

 

June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Selling, general and administrative

$

5,552

 

 

$

4,871

 

 

$

10,649

 

 

$

10,402

 

Research and development and engineering

 

601

 

 

 

542

 

 

 

1,160

 

 

 

985

 

Cost of revenue

 

78

 

 

 

462

 

 

 

499

 

 

 

954

 

Total share-based compensation expense

$

6,231

 

 

$

5,875

 

 

$

12,308

 

 

$

12,341

 

Schedule of Share Based Payment Award Performance Stock Awards Valuation Assumptions

The grant-date fair value per unit of the hybrid PSUs granted during the six months ended June 28, 2024 was estimated using the Monte Carlo valuation method with the following assumptions:

 

Three Months Ended
June 28, 2024

 

Grant-date stock price

$

157.48

 

Expected volatility

 

36.90

%

Risk-free interest rate

 

4.35

%

Expected annual dividend yield

 

 

Fair value

$

180.98

 

Schedule of Share Based Payment Award Stock Options Valuation Assumptions

The aggregate Black-Scholes fair value of $3.3 million for the stock options granted during the six months ended June 28, 2024 was estimated using the following assumptions as of the grant date:

 

Six Months Ended
June 28, 2024

 

Expected option term in years

 

4.5

 

Expected volatility

 

40.3

%

Risk-free interest rate

 

4.2

%

Expected annual dividend yield

 

 

Amended and Restated 2010 Incentive Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Restricted Stock Units Issued and Outstanding

The table below summarizes activities relating to RSUs issued and outstanding under the Company’s Amended and Restated 2010 Incentive Plan during the six months ended June 28, 2024:

 

Shares
(In thousands)

 

 

Weighted
Average Grant
Date Fair Value

 

Unvested at December 31, 2023

 

206

 

 

$

143.97

 

Granted

 

97

 

 

$

158.99

 

Vested

 

(97

)

 

$

140.29

 

Forfeited

 

(7

)

 

$

151.54

 

Unvested at June 28, 2024

 

199

 

 

$

152.83

 

Expected to vest as of June 28, 2024

 

178

 

 

 

 

Performance-Based Awards Issued and Outstanding

The table below summarizes the activities relating to the performance-based awards issued and outstanding under the Company’s Amended and Restated 2010 Incentive Plan during the six months ended June 28, 2024:

 

Shares
(In thousands)

 

 

Weighted
Average Grant-
Date Fair Value

 

Unvested at December 31, 2023

 

205

 

 

$

160.24

 

Granted

 

80

 

 

$

177.06

 

Performance adjustments(1)

 

16

 

 

$

166.64

 

Vested

 

(45

)

 

$

168.60

 

Forfeited

 

(8

)

 

$

166.22

 

Unvested at June 28, 2024

 

248

 

 

$

165.12

 

Expected to vest as of June 28, 2024

 

231

 

 

 

 

(1) The amount shown represents performance adjustments related to the performance-based awards vested during the six months ended June 28, 2024.

Stock Options Issued and Outstanding

The table below summarizes the activities relating to stock options issued and outstanding under the Company’s Amended and Restated 2010 Incentive Plan during the six months ended June 28, 2024:

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares
(In thousands)

 

 

Weighted
Average Exercise Price

 

Outstanding as of December 31, 2023

 

132

 

 

$

102.86

 

Granted

 

53

 

 

$

157.48

 

Exercised

 

 

 

$

 

Forfeited or expired

 

 

 

$

 

Outstanding as of June 28, 2024

 

185

 

 

$

118.57

 

Exercisable as of June 28, 2024

 

87

 

 

 

 

Expected to vest as of June 28, 2024

 

98